Segmental chromosome aberrations and clinical response impact outcome of inss stage Ill patients ≥18 months with unfavorable histology and without MYCN amplification: A Children's Oncology Group (COG) report.
Publication
, Conference
Pinto, NR; Naranjo, A; Hibbitts, E; Ding, X; Tibbetts, R; Kennedy, R; Pfau, R; Hogarty, MD; Kreissman, SG; Irwin, M; Park, JR; Asgharzadeh, S
Published in: JOURNAL OF CLINICAL ONCOLOGY
2020
Duke Scholars
Published In
JOURNAL OF CLINICAL ONCOLOGY
EISSN
1527-7755
ISSN
0732-183X
Publication Date
2020
Volume
38
Issue
15
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Pinto, N. R., Naranjo, A., Hibbitts, E., Ding, X., Tibbetts, R., Kennedy, R., … Asgharzadeh, S. (2020). Segmental chromosome aberrations and clinical response impact outcome of inss stage Ill patients ≥18 months with unfavorable histology and without MYCN amplification: A Children's Oncology Group (COG) report. In JOURNAL OF CLINICAL ONCOLOGY (Vol. 38).
Pinto, Navin R., Arlene Naranjo, Emily Hibbitts, Xiangming Ding, Rachelle Tibbetts, Rebekah Kennedy, Ruthann Pfau, et al. “Segmental chromosome aberrations and clinical response impact outcome of inss stage Ill patients ≥18 months with unfavorable histology and without MYCN amplification: A Children's Oncology Group (COG) report.” In JOURNAL OF CLINICAL ONCOLOGY, Vol. 38, 2020.
Pinto NR, Naranjo A, Hibbitts E, Ding X, Tibbetts R, Kennedy R, et al. Segmental chromosome aberrations and clinical response impact outcome of inss stage Ill patients ≥18 months with unfavorable histology and without MYCN amplification: A Children's Oncology Group (COG) report. In: JOURNAL OF CLINICAL ONCOLOGY. 2020.
Pinto, Navin R., et al. “Segmental chromosome aberrations and clinical response impact outcome of inss stage Ill patients ≥18 months with unfavorable histology and without MYCN amplification: A Children's Oncology Group (COG) report.” JOURNAL OF CLINICAL ONCOLOGY, vol. 38, no. 15, 2020.
Pinto NR, Naranjo A, Hibbitts E, Ding X, Tibbetts R, Kennedy R, Pfau R, Hogarty MD, Kreissman SG, Irwin M, Park JR, Asgharzadeh S. Segmental chromosome aberrations and clinical response impact outcome of inss stage Ill patients ≥18 months with unfavorable histology and without MYCN amplification: A Children's Oncology Group (COG) report. JOURNAL OF CLINICAL ONCOLOGY. 2020.
Published In
JOURNAL OF CLINICAL ONCOLOGY
EISSN
1527-7755
ISSN
0732-183X
Publication Date
2020
Volume
38
Issue
15
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences